©The Author(s) 2018.
World J Diabetes. Jan 15, 2018; 9(1): 1-24
Published online Jan 15, 2018. doi: 10.4239/wjd.v9.i1.1
Published online Jan 15, 2018. doi: 10.4239/wjd.v9.i1.1
Table 1 Cardiac autonomic neuropathy in type 1 and type 2 diabetes mellitus: Differences in relation to risk factors and natural history[21]
| Risk factors | Type 1 DM | Type 2 DM |
| Age | + | + |
| Gender (female) | + | - |
| Obesity | - | + |
| Hyperinsulinemia | NA | + |
| Duration of DM | ++ | ++ |
| Smoking | + | + |
| HbA1c | ++ | ++ |
| Hypertension | ++ | + |
| Retinopathy | ++ | + |
| Hypertriglyceridemia | + | + |
| Classical DPN | ++ | ++ |
| Microalbuminuria | ++ | ++ |
| Dyslipoproteinemia (> LDL and < HDL | + | (+) |
| Prevalence at diagnosis of DM | 7.70% | 5% |
| Prevalence after 10 yr | 38% | 65% |
| Prevalence (random) | 25% | 34% |
- Citation: Serhiyenko VA, Serhiyenko AA. Cardiac autonomic neuropathy: Risk factors, diagnosis and treatment. World J Diabetes 2018; 9(1): 1-24
- URL: https://www.wjgnet.com/1948-9358/full/v9/i1/1.htm
- DOI: https://dx.doi.org/10.4239/wjd.v9.i1.1